SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Caitlin E McOmish, Geoff Pavey, Andrew Gibbons, Shaun Hopper, Madhara Udawela, Elizabeth Scarr, Brian Dean, Lower [3H]LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia, Journal of Affective Disorders, 2016, 190, 241

    CrossRef

  2. 2
    Rajapillai L. I. Pillai, Dnyanesh N. Tipre, Metabotropic glutamate receptor 5 – a promising target in drug development and neuroimaging, European Journal of Nuclear Medicine and Molecular Imaging, 2016,

    CrossRef

  3. 3
    Martin Engel, Peta Snikeris, Natalie Matosin, Kelly Anne Newell, Xu-Feng Huang, Elisabeth Frank, mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia, Psychopharmacology, 2016,

    CrossRef

  4. 4
    Michel Neidhart, DNA Methylation and Complex Human Disease, 2016,

    CrossRef

  5. 5
    Karin E. Borgmann-Winter, Hoau-Yan Wang, Rabindranath Ray, Brooke R. Willis, Paul J. Moberg, Nancy E. Rawson, Raquel E. Gur, Bruce I. Turetsky, Chang-Gyu Hahn, Altered G Protein Coupling in Olfactory Neuroepithelial Cells From Patients With Schizophrenia, Schizophrenia Bulletin, 2015, sbv129

    CrossRef

  6. 6
    Sarah N. Isherwood, Anton Pekcec, Janet R. Nicholson, Trevor W. Robbins, Jeffrey W. Dalley, Dissociable effects of mGluR5 allosteric modulation on distinct forms of impulsivity in rats: interaction with NMDA receptor antagonism, Psychopharmacology, 2015, 232, 18, 3327

    CrossRef

  7. 7
    Akihide Kinoshita, Ryu Takizawa, Shinsuke Koike, Yoshihiro Satomura, Shingo Kawasaki, Yuki Kawakubo, Kohei Marumo, Mamoru Tochigi, Tsukasa Sasaki, Yukika Nishimura, Kiyoto Kasai, Effect of metabotropic glutamate receptor-3 variants on prefrontal brain activity in schizophrenia: An imaging genetics study using multi-channel near-infrared spectroscopy, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2015, 62, 14

    CrossRef

  8. 8
    Lesley A. McCollum, Courtney K. Walker, Joy K. Roche, Rosalinda C. Roberts, Elevated Excitatory Input to the Nucleus Accumbens in Schizophrenia: A Postmortem Ultrastructural Study, Schizophrenia Bulletin, 2015, 41, 5, 1123

    CrossRef

  9. 9
    Dhaval Patel, Prashant S. Kharkar, Mukesh Nandave, Emerging roles of system antiporter and its inhibition in CNS disorders, Molecular Membrane Biology, 2015, 32, 4, 89

    CrossRef

  10. 10
    Emma L Burrows, Caitlin E McOmish, Laetitia S Buret, Maarten Van den Buuse, Anthony J Hannan, Environmental Enrichment Ameliorates Behavioral Impairments Modeling Schizophrenia in Mice Lacking Metabotropic Glutamate Receptor 5, Neuropsychopharmacology, 2015, 40, 8, 1947

    CrossRef

  11. 11
    S. Hossein Fatemi, Timothy D. Folsom, GABA receptor subunit distribution and FMRP–mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism, Schizophrenia Research, 2015, 167, 1-3, 42

    CrossRef

  12. 12
    Stefanie Dedeurwaerdere, Stephanie Boets, Pieter Janssens, Hilde Lavreysen, Thomas Steckler, In the grey zone between epilepsy and schizophrenia: alterations in group II metabotropic glutamate receptors, Acta Neurologica Belgica, 2015, 115, 3, 221

    CrossRef

  13. 13
    A Ledonne, A Nobili, E C Latagliata, V Cavallucci, E Guatteo, S Puglisi-Allegra, M D'Amelio, N B Mercuri, Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons, Molecular Psychiatry, 2015, 20, 8, 959

    CrossRef

  14. 14
    Amr Ellaithy, Jason Younkin, Javier González-Maeso, Diomedes E. Logothetis, Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment, Trends in Neurosciences, 2015, 38, 8, 506

    CrossRef

  15. 15
    M Föcking, L M Lopez, J A English, P Dicker, A Wolff, E Brindley, K Wynne, G Cagney, D R Cotter, Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia, Molecular Psychiatry, 2015, 20, 4, 424

    CrossRef

  16. 16
    Natalie Matosin, Francesca Fernandez-Enright, Jeremy S. Lum, Kelly A. Newell, Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment, Neuropharmacology, 2015,

    CrossRef

  17. 17
    Wei Hu, Matthew L. MacDonald, Daniel E. Elswick, Robert A. Sweet, The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies, Annals of the New York Academy of Sciences, 2015, 1338, 1
  18. 18
    Hyekyung P. Cho, Pedro M. Garcia-Barrantes, John T. Brogan, Corey R. Hopkins, Colleen M. Niswender, Alice L. Rodriguez, Daryl F. Venable, Ryan D. Morrison, Michael Bubser, J. Scott Daniels, Carrie K. Jones, P. Jeffrey Conn, Craig W. Lindsley, Chemical Modulation of Mutant mGlu1Receptors Derived from DeleteriousGRM1Mutations Found in Schizophrenics, ACS Chemical Biology, 2014, 9, 10, 2334

    CrossRef

  19. 19
    Adam J. Funk, Vahram Haroutunian, James H. Meador-Woodruff, Robert E. McCullumsmith, Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia, Schizophrenia Research, 2014, 159, 1, 130

    CrossRef

  20. 20
    Lucyna Pomierny-Chamioło, Kinga Rup, Bartosz Pomierny, Ewa Niedzielska, Peter W. Kalivas, Małgorzata Filip, Metabotropic glutamatergic receptors and their ligands in drug addiction, Pharmacology & Therapeutics, 2014, 142, 3, 281

    CrossRef

  21. 21
    Takashi Uehara, Tomiki Sumiyoshi, Dan Rujescu, Just Genius, Tadasu Matsuoka, Ichiro Takasaki, Hiroko Itoh, Masayoshi Kurachi, Neonatal exposure to MK-801 reduces mRNA expression of mGlu3 receptors in the medial prefrontal cortex of adolescent rats, Synapse, 2014, 68, 5
  22. 22
    Kelly A Newell, Natalie Matosin, Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics, BMC Psychiatry, 2014, 14, 1, 23

    CrossRef

  23. 23
    Nicholas E. Clifton, Nadège Morisot, Sylvie Girardon, Mark J. Millan, Florence Loiseau, Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine, Psychopharmacology, 2013, 225, 3, 579

    CrossRef

  24. 24
    E. Iscru, H. Goddyn, T. Ahmed, Z. Callaerts-Vegh, R. D'Hooge, D. Balschun, Improved spatial learning is associated with increased hippocampal but not prefrontal long-term potentiation in mGluR4 knockout mice, Genes, Brain and Behavior, 2013, 12, 6
  25. 25
    Natalie Matosin, Elisabeth Frank, Chao Deng, Xu-Feng Huang, Kelly A. Newell, Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment, Schizophrenia Research, 2013, 146, 1-3, 170

    CrossRef

  26. 26
    Natalie Matosin, Kelly A. Newell, Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia, Neuroscience & Biobehavioral Reviews, 2013, 37, 3, 256

    CrossRef

  27. 27
    S H Fatemi, T D Folsom, R J Rooney, P D Thuras, mRNA and protein expression for novel GABAA receptors θ and ρ2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway, Translational Psychiatry, 2013, 3, 6, e271

    CrossRef

  28. 28
    Jun Toyohara, Muneyuki Sakata, Masayuki Fujinaga, Tomoteru Yamasaki, Keiichi Oda, Kenji Ishii, Ming Rong Zhang, Cristina Maria Moriguchi Jeckel, Kiichi Ishiwata, Preclinical and the first clinical studies on [11C]ITMM for mapping metabotropic glutamate receptor subtype 1 by positron emission tomography, Nuclear Medicine and Biology, 2013, 40, 2, 214

    CrossRef

  29. 29
    Adam L. Halberstadt, Mark A. Geyer, Serotonergic hallucinogens as translational models relevant to schizophrenia, The International Journal of Neuropsychopharmacology, 2013, 16, 10, 2165

    CrossRef

  30. 30
    Hirohiko Hikichi, Ayaka Kaku, Jun-ichi Karasawa, Shigeyuki Chaki, Stimulation of Metabotropic Glutamate (mGlu) 2 Receptor and Blockade of mGlu1 Receptor Improve Social Memory Impairment Elicited by MK-801 in Rats, Journal of Pharmacological Sciences, 2013, 122, 1, 10

    CrossRef

  31. 31
    Saurav Seshadri, Mariela Zeledon, Akira Sawa, Synapse-specific contributions in the cortical pathology of schizophrenia, Neurobiology of Disease, 2013, 53, 26

    CrossRef

  32. 32
    Hannah K. Delille, Mario Mezler, Gerard J. Marek, The two faces of the pharmacological interaction of mGlu2 and 5-HT2A – Relevance of receptor heterocomplexes and interaction through functional brain pathways, Neuropharmacology, 2013, 70, 296

    CrossRef

  33. 33
    Maria D. Rubio, Jana B. Drummond, James H. Meador-Woodruff, Glutamate Receptor Abnormalities in Schizophrenia: Implications for Innovative Treatments, Biomolecules and Therapeutics, 2012, 20, 1, 1

    CrossRef

  34. You have free access to this content34
    Andrea de Bartolomeis, Karen Kathleen Szumlinski, Group 1 metabotropic glutamate receptors and schizophrenia, Wiley Interdisciplinary Reviews: Membrane Transport and Signaling, 2012, 1, 1
  35. 35
    Matthew J. Fell, David L. McKinzie, James A. Monn, Kjell A. Svensson, Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia, Neuropharmacology, 2012, 62, 3, 1473

    CrossRef

  36. 36
    Francesco Matrisciano, Patricia Tueting, Stefania Maccari, Ferdinando Nicoletti, Alessandro Guidotti, Pharmacological Activation of Group-II Metabotropic Glutamate Receptors Corrects a Schizophrenia-Like Phenotype Induced by Prenatal Stress in Mice, Neuropsychopharmacology, 2012, 37, 4, 929

    CrossRef

  37. 37
    Khosrow Rezvani, Kelli Baalman, Yanfen Teng, Maureen P. Mee, Simon P. Dawson, Hongmin Wang, Mariella De Biasi, R. John Mayer, Proteasomal degradation of the metabotropic glutamate receptor 1α is mediated by Homer-3 via the proteasomal S8 ATPase, Journal of Neurochemistry, 2012, 122, 1
  38. 38
    Elisabeth Frank, Kelly Anne Newell, Xu-Feng Huang, Density of metabotropic glutamate receptors 2 and 3 (mGluR2/3) in the dorsolateral prefrontal cortex does not differ with schizophrenia diagnosis but decreases with age, Schizophrenia Research, 2011, 128, 1-3, 56

    CrossRef

  39. 39
    Louisa Lyon, Philip WJ Burnet, James NC Kew, Corrado Corti, J Nicholas P Rawlins, Tracy Lane, Bianca De Filippis, Paul J Harrison, David M Bannerman, Fractionation of Spatial Memory in GRM2/3 (mGlu2/mGlu3) Double Knockout Mice Reveals a Role for Group II Metabotropic Glutamate Receptors at the Interface Between Arousal and Cognition, Neuropsychopharmacology, 2011, 36, 13, 2616

    CrossRef

  40. 40
    Monsheel S. Sodhi, Micah Simmons, Robert McCullumsmith, Vahram Haroutunian, James H. Meador-Woodruff, Glutamatergic Gene Expression Is Specifically Reduced in Thalamocortical Projecting Relay Neurons in Schizophrenia, Biological Psychiatry, 2011, 70, 7, 646

    CrossRef

  41. 41
    Adam L. Halberstadt, Virginia D. Lehmann-Masten, Mark A. Geyer, Susan B. Powell, Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice, Psychopharmacology, 2011, 215, 1, 81

    CrossRef

  42. 42
    Himashi Anver, Peter D Ward, Andor Magony, Martin Vreugdenhil, NMDA Receptor Hypofunction Phase Couples Independent γ-Oscillations in the Rat Visual Cortex, Neuropsychopharmacology, 2011, 36, 2, 519

    CrossRef

  43. 43
    Caitlin A. Jones, Angus M. Brown, Dorothee P. Auer, Kevin. C. F. Fone, The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat, Psychopharmacology, 2011, 214, 1, 269

    CrossRef

  44. 44
    Anteneh M. Feyissa, William L. Woolverton, Jose J. Miguel-Hidalgo, Zhixia Wang, Patrick B. Kyle, Gregor Hasler, Craig A. Stockmeier, Abiye H. Iyo, Beata Karolewicz, Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010, 34, 2, 279

    CrossRef

  45. 45
    Suat Ying Tan Cherlyn, Puay San Woon, Jian Jun Liu, Wei Yi Ong, Guo Chuan Tsai, Kang Sim, Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: A decade of advance, Neuroscience & Biobehavioral Reviews, 2010, 34, 6, 958

    CrossRef

  46. 46
    Anne Lesage, Thomas Steckler, Metabotropic glutamate mGlu1 receptor stimulation and blockade: Therapeutic opportunities in psychiatric illness, European Journal of Pharmacology, 2010, 639, 1-3, 2

    CrossRef

  47. 47
    Gerard J. Marek, Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition, European Journal of Pharmacology, 2010, 639, 1-3, 81

    CrossRef

  48. 48
    John H. Krystal, Sanjay J. Mathew, D. Cyril DʼSouza, Amir Garakani, Handan Gunduz-Bruce, Dennis S. Charney, Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists, CNS Drugs, 2010, 24, 8, 669

    CrossRef

  49. 49
    H. Moore, The Role of Rodent Models in The Discovery of New Treatments for Schizophrenia: Updating Our Strategy, Schizophrenia Bulletin, 2010, 36, 6, 1066

    CrossRef

  50. 50
    B. Altinbilek, D. Manahan-Vaughan, A specific role for group II metabotropic glutamate receptors in hippocampal long-term depression and spatial memory, Neuroscience, 2009, 158, 1, 149

    CrossRef

  51. 51
    Laura Gray, Maarten van den Buuse, Elizabeth Scarr, Brian Dean, Anthony J. Hannan, Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-d-aspartic acid receptor up-regulation, The International Journal of Neuropsychopharmacology, 2009, 12, 01, 45

    CrossRef

  52. 52
    A. Erb, N. Franck, Cytoarchitecture cérébrale dans la schizophrénie, PSN, 2009, 7, 1, 23

    CrossRef

  53. 53
    Michele Bellesi, Marcello Melone, Alessandro Gubbini, Silvia Battistacci, Fiorenzo Conti, GLT-1 upregulation impairs prepulse inhibition of the startle reflex in adult rats, Glia, 2009, 57, 7
  54. 54
    José L. Moreno, Stuart C. Sealfon, Javier González-Maeso, Group II metabotropic glutamate receptors and schizophrenia, Cellular and Molecular Life Sciences, 2009, 66, 23, 3777

    CrossRef

  55. 55
    Rayna M. Bauzo, Heather L. Kimmel, Leonard L. Howell, Interactions between the mGluR2/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys, Pharmacology Biochemistry and Behavior, 2009, 94, 1, 204

    CrossRef

  56. 56
    Pablo A. Gaspar, M. Leonor Bustamante, Hernán Silva, Francisco Aboitiz, Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications, Journal of Neurochemistry, 2009, 111, 4
  57. 57
    Richard J. Beninger, Katharine J. Tuerke, Jennifer K. Forsyth, Andrew Giles, Lihua Xue, Roland J. Boegman, Khem Jhamandas, Neonatal ventral hippocampal lesions in male and female rats: Effects on water maze, locomotor activity, plus-maze and prefrontal cortical GABA and glutamate release in adulthood, Behavioural Brain Research, 2009, 202, 2, 198

    CrossRef

  58. 58
    John E. Lisman, Joseph T. Coyle, Robert W. Green, Daniel C. Javitt, Francine M. Benes, Stephan Heckers, Anthony A. Grace, Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia, Trends in Neurosciences, 2008, 31, 5, 234

    CrossRef

  59. 59
    David A Baker, Aric Madayag, Lars V Kristiansen, James H Meador-Woodruff, Vahram Haroutunian, Ilangovan Raju, Contribution of Cystine–Glutamate Antiporters to the Psychotomimetic Effects of Phencyclidine, Neuropsychopharmacology, 2008, 33, 7, 1760

    CrossRef

  60. 60
    Jonathan Mill, Thomas Tang, Zachary Kaminsky, Tarang Khare, Simin Yazdanpanah, Luigi Bouchard, Peixin Jia, Abbas Assadzadeh, James Flanagan, Axel Schumacher, Sun-Chong Wang, Arturas Petronis, Epigenomic Profiling Reveals DNA-Methylation Changes Associated with Major Psychosis, The American Journal of Human Genetics, 2008, 82, 3, 696

    CrossRef

  61. 61
    Leah J Sartorius, Daniel R Weinberger, Thomas M Hyde, Paul J Harrison, Joel E Kleinman, Barbara K Lipska, Expression of a GRM3 Splice Variant is Increased in the Dorsolateral Prefrontal Cortex of Individuals Carrying a Schizophrenia Risk SNP, Neuropsychopharmacology, 2008, 33, 11, 2626

    CrossRef

  62. 62
    Paul Gierke, CongJian Zhao, Hans-Gert Bernstein, Cornelia Noack, Rene Anand, Uwe Heinemann, Karl-Heinz Braunewell, Implication of neuronal Ca2+-sensor protein VILIP-1 in the glutamate hypothesis of schizophrenia, Neurobiology of Disease, 2008, 32, 1, 162

    CrossRef

  63. 63
    Amir Krivoy, Tsvi Fischel, Abraham Weizman, The possible involvement of metabotropic glutamate receptors in schizophrenia, European Neuropsychopharmacology, 2008, 18, 6, 395

    CrossRef

  64. 64
    Corrado Corti, Luca Crepaldi, Silvia Mion, Adelheid L. Roth, John H. Xuereb, Francesco Ferraguti, Altered Dimerization of Metabotropic Glutamate Receptor 3 in Schizophrenia, Biological Psychiatry, 2007, 62, 7, 747

    CrossRef

  65. 65
    Gulnur Sh. Burbaeva, Irina S. Boksha, Elena B. Tereshkina, Olga K. Savushkina, Lubov’ I. Starodubtseva, Marina S. Turishcheva, Elizabeta Mukaetova-Ladinska, Systemic Neurochemical Alterations in Schizophrenic Brain: Glutamate Metabolism in Focus, Neurochemical Research, 2007, 32, 9, 1434

    CrossRef

  66. 66
    M. Pietraszek, J. Nagel, A. Gravius, D. Schäfer, W. Danysz, The role of group I metabotropic glutamate receptors in schizophrenia, Amino Acids, 2007, 32, 2, 173

    CrossRef

  67. 67
    H. Le-Niculescu, Y. Balaraman, S. Patel, J. Tan, K. Sidhu, R.E. Jerome, H.J. Edenberg, R. Kuczenski, M.A. Geyer, J.I. Nurnberger, S.V. Faraone, M.T. Tsuang, A.B. Niculescu, Towards understanding the schizophrenia code: An expanded convergent functional genomics approach, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2007, 144B, 2
  68. 68
    Karen L. Baracskay, Vahram Haroutunian, James H. Meador-Woodruff, Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex, Synapse, 2006, 60, 4
  69. 69
    Scott Duncan, Peter Koulen, Glutamate receptor, metabotropic, type 5, AfCS-Nature Molecule Pages, 2006,

    CrossRef

  70. 70
    Holly A. Erdely, Carol A. Tamminga, Rosalinda C. Roberts, Michael W. Vogel, Regional alterations in RGS4 protein in schizophrenia, Synapse, 2006, 59, 8
  71. 71
    John H. Krystal, Bita Moghaddam, Contributions of Glutamate and GABA Systems to the Neurobiology and Treatment of Schizophrenia,
  72. 72
    William V. Bobo, Judith L. Rapoport, Anissa Abi-Dargham, S. Hossein Fatemi, Herbert Y. Meltzer, The Neurobiology of Schizophrenia,